Harvard Bioscience (HBIO) came out with quarterly earnings of $0.02 per share, in line with the Zacks Consensus Estimate. This compares to earnings of$0.06 per share a year ago. These figures are adjusted for non-recurring items. A quarter ago, it was expected that this medical instruments maker would post earnings of $0.05 per share when it actually produced earnings of$0.04, delivering a surprise of -20%. Over the last four quarters, the company has not been able to surpass consensus EPS estimates. Harv ...